FindTrial
Sign In

The effects of remimazolam verus dexmedetomidine on short-term postoperative sleep quality in elderly patients undergoing ERCP

The effects of remimazolam on short-term postoperative sleep quality in elderly patients undergoing ERCP

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052435
Enrollment
Unknown
Registered
2021-10-26
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endoscopic retrograde cholangiopancreatography

Interventions

saline group :saline
remimazolam group:remimazolam

Sponsors

Liaocheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 89 Years

Inclusion criteria

Inclusion criteria: 65 – 89 years; ASA II-III; patients planning ERCP.

Exclusion criteria

Exclusion criteria: BMI >=28kg/m2;; uncontrolled hypertension 180mmHg SBP, diastolic BP 110mmHg; allergic to anesthetics or their composition; previous history of mental illness, history of epilepsy; refused to sign informed consent.

Design outcomes

Primary

MeasureTime frame
PSQI;Sleep Quality;Postoperative complications;—

Countries

China

Contacts

Public ContactZhao Tonghang

Department of Anesthesiology Liaocheng People's Hospital

lbzthgn@163.com+86 15275662176

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026